# A Pharmacokinetic Study of PLENVU® in Healthy Subjects

> **NCT03437265** · PHASE1 · COMPLETED · sponsor: **Norgine** · enrollment: 19 (actual)

## Conditions studied

- Pharmacokinetic

## Interventions

- **DRUG:** PLENVU powder for oral solution

## Key facts

- **NCT ID:** NCT03437265
- **Lead sponsor:** Norgine
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-03
- **Primary completion:** 2020-10-05
- **Final completion:** 2020-10-05
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2023-11-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03437265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03437265, "A Pharmacokinetic Study of PLENVU® in Healthy Subjects". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03437265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*